BECTON, DICKINSON AND COMPANY Income (Loss) from Equity Method Investments
BECTON, DICKINSON AND COMPANY (BDX) reported Income (Loss) from Equity Method Investments of $13.00 million for the 12-month period ending 2020-09-30, per its 10-K filed 2020-11-25.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2020-11-25
- BECTON, DICKINSON AND COMPANY income (loss) from equity method investments for fiscal 2020 was $13.00M, a 27.78% decline from fiscal 2019.
- BECTON, DICKINSON AND COMPANY income (loss) from equity method investments for fiscal 2019 was $18.00M, a 125.00% increase from fiscal 2018.
- BECTON, DICKINSON AND COMPANY income (loss) from equity method investments for fiscal 2018 was $8.00M, a 166.67% increase from fiscal 2017.
- BECTON, DICKINSON AND COMPANY income (loss) from equity method investments for fiscal 2017 was $3.00M, a 62.50% decline from fiscal 2016.
| Period end | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|
| 2020-09-30 | $13.00M 10-K · filed 2020-11-25 | |
| 2019-09-30 | $18.00M 10-K · filed 2020-11-25 | |
| 2018-09-30 | $8.00M 10-K · filed 2020-11-25 | |
| 2017-09-30 | $3.00M 10-K · filed 2019-11-27 | |
| 2016-09-30 | $8.00M 10-K · filed 2018-11-21 | |
| 2015-09-30 | $9.00M 10-K · filed 2017-11-22 | |
| 2014-09-30 | $13.00M 10-K · filed 2016-11-23 | |
| 2013-09-30 | $5.00M 10-K · filed 2015-11-25 | |
| 2012-09-30 | $12.00M 8-K · filed 2015-03-13 | $12.08M 10-K · filed 2012-11-21 |
| 2011-09-30 | $3.00M 10-K · filed 2013-11-27 | $3.02M 10-K · filed 2011-11-23 |
| 2010-09-30 | $4.85M 10-K · filed 2012-11-21 | |
| 2009-09-30 | $4.54M 10-K · filed 2011-11-23 | |
| 2008-09-30 | $4.64M 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |